Title:
化合物
Document Type and Number:
Japanese Patent JP2005533858
Kind Code:
A
Abstract:
Compounds of formula (I): wherein variable groups are as defined within; for use in the inhibition of 11betaHSD1 are described.
Inventors:
Burton, Peter John
Clark, David Stephen
Davies, Christopher Daniel
Hargreaves, Rodney Bryan
Peace, Janet Elizabeth
Rankin, Maureen Teresa
Clark, David Stephen
Davies, Christopher Daniel
Hargreaves, Rodney Bryan
Peace, Janet Elizabeth
Rankin, Maureen Teresa
Application Number:
JP2004523925A
Publication Date:
November 10, 2005
Filing Date:
July 23, 2003
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
A61K31/12; A61K31/121; A61K31/137; A61K31/165; A61K31/18; A61K31/216; A61K31/275; A61K31/381; A61K31/40; A61K31/4035; A61K31/4184; A61K31/4196; A61K31/426; A61K31/4406; A61K31/4409; A61K31/4436; A61K31/445; A61K31/495; A61K31/496; A61K31/497; A61K31/50; A61K31/505; A61K31/5375; A61K31/5377; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P9/12; A61P11/00; A61P19/10; A61P25/24; A61P25/28; A61P27/06; A61P43/00; C07C49/233; C07C49/76; C07C49/782; C07C49/788; C07C49/792; C07C49/80; C07C49/807; C07C49/813; C07C49/825; C07C49/83; C07C49/84; C07C69/76; C07C205/36; C07C205/45; C07C211/48; C07C211/52; C07C225/16; C07C225/22; C07C233/25; C07C233/76; C07C235/46; C07C235/60; C07C235/64; C07C239/14; C07C255/37; C07C255/54; C07C311/08; C07C311/13; C07C311/16; C07C311/20; C07C311/29; C07C317/14; C07C317/22; C07C317/24; C07C317/44; C07C323/62; C07D209/44; C07D249/08; C07D209/48; C07D211/46; C07D211/52; C07D211/96; C07D213/30; C07D213/50; C07D213/65; C07D213/74; C07D213/76; C07D235/12; C07D235/28; C07D237/08; C07D239/34; C07D239/38; C07D277/10; C07D277/20; C07D277/24; C07D277/26; C07D277/32; C07D277/64; C07D295/096; C07D295/104; C07D295/22; C07D295/26; C07D307/71; C07D309/12; C07D317/58; C07D333/16; C07D333/18; C07D333/22; C07D333/28; C07D333/34; C07D333/38; C07D333/56; C07D401/06; C07D405/06; C07D409/06; C07D417/06; C07D521/00; A61K; C07C; (IPC1-7): A61K31/121; A61K31/137; A61K31/165; A61K31/18; A61K31/216; A61K31/275; A61K31/381; A61K31/40; A61K31/4035; A61K31/4184; A61K31/4196; A61K31/426; A61K31/4406; A61K31/4409; A61K31/4436; A61K31/445; A61K31/495; A61K31/496; A61K31/497; A61K31/50; A61K31/505; A61K31/5375; A61K31/5377; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P9/12; A61P11/00; A61P19/10; A61P25/24; A61P25/28; A61P27/06; A61P43/00; C07C49/76; C07C49/788; C07C49/80; C07C49/807; C07C49/825; C07C49/84; C07C205/36; C07C211/48; C07C211/52; C07C233/25; C07C233/76; C07C235/46; C07C239/14; C07C255/54; C07C311/08; C07C311/16; C07C311/20; C07C311/29; C07C317/14; C07C323/62; C07D209/48; C07D211/52; C07D213/30; C07D235/12; C07D237/08; C07D239/34; C07D249/08; C07D277/20; C07D277/24; C07D277/26; C07D277/32; C07D277/64; C07D295/22; C07D333/16; C07D333/18; C07D333/56; C07D401/06; C07D409/06; C07D417/06
Attorney, Agent or Firm:
Kazuo Shamoto
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hisako Nozaki
Tadashi Masui
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Hisako Nozaki